Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2013; 19(16): 2481-2491
Published online Apr 28, 2013. doi: 10.3748/wjg.v19.i16.2481
Published online Apr 28, 2013. doi: 10.3748/wjg.v19.i16.2481
Table 1 Inhibition ratio and 50% inhibitory concentration, and reversal index of 10 μmol/L emodin in HepG2/oxaliplatin (mean ± SD) (n = 5)
| OXA concentration (μmol/L) | 3.125 | 6.25 | 12.5 | 25 | 50 | 100 | IC50 (μmol/L) | Reversal index |
| IR in control (%) | 9.76 ± 1.18 | 11.94 ± 1.30 | 13.95 ± 1.11 | 14.58 ± 1.02 | 28.06 ± 2.01 | 63.95 ± 4.71 | 120.78 ± 9.68 | 3.05 |
| IR in emodin (%) | 12.35 ± 1.3a | 16.76 ± 1.3a | 21.69 ± 1.6a | 29.87 ± 1.55b | 48.14 ± 2.09b | 80.34 ± 3.00b | 39.65 ± 5.43 |
- Citation: Chen G, Qiu H, Ke SD, Hu SM, Yu SY, Zou SQ. Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling. World J Gastroenterol 2013; 19(16): 2481-2491
- URL: https://www.wjgnet.com/1007-9327/full/v19/i16/2481.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i16.2481